Medicare Enrolled
Dr. Deborah Kirby, MD
Neurology · High Point, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kirby from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kirby?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kirby
Dr. Deborah Kirby is a neurology specialist in High Point, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kirby performed 12,905 Medicare services across 582 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kirby received a total of $9,584 from 67 pharmaceutical and/or device companies across 541 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kirby is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 7% volume in NC
$9,584 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,905
Medicare services
Top 7% in NC for neurology
582
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~679 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
12,245 | $5 | $13 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
208 | $79 | $176 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
130 | $57 | $120 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
125 | $115 | $303 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
102 | $69 | $256 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
30 | $114 | $360 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
23 | $148 | $433 |
| Nerve conduction study, 3-4 tests A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function. |
14 | $78 | $228 |
| New patient office visit, complex (60-74 min) | 14 | $161 | $382 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
14 | $99 | $225 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,584
Total received (2018-2024)
Avg $1,369/year across 7 years
Top 23% in NC for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
541
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,353 (97.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$231 (2.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,041
2023
$2,283
2022
$914
2021
$585
2020
$420
2019
$1,454
2018
$1,888
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$354
UCB, Inc.
$209
PFIZER INC.
$188
ARGENX US, INC.
$158
Biogen, Inc.
$142
Amneal Pharmaceuticals LLC
$90
Takeda Pharmaceuticals U.S.A., Inc.
$80
JAZZ PHARMACEUTICALS INC.
$79
Lundbeck LLC
$77
Amgen Inc.
$71
MDD US Operations, LLC
$67
Neurocrine Biosciences, Inc.
$61
Genentech USA, Inc.
$59
TG Therapeutics, Inc.
$56
ACADIA Pharmaceuticals Inc
$45
EMD Serono, Inc.
$43
Alexion Pharmaceuticals, Inc.
$41
BANNER LIFE SCIENCES, LLC
$33
Lilly USA, LLC
$32
Averitas Pharma Inc.
$29
Novartis Pharmaceuticals Corporation
$27
Eisai Inc.
$20
Otsuka America Pharmaceutical, Inc.
$18
Alnylam Pharmaceuticals Inc.
$18
Grifols USA, LLC
$17
Teva Pharmaceuticals USA, Inc.
$14
Abbott Laboratories
$14
Top 3 companies account for 36.8% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$803
UCB, Inc.
$749
Teva Pharmaceuticals USA, Inc.
$590
Novartis Pharmaceuticals Corporation
$558
Biogen, Inc.
$529
EMD Serono, Inc.
$419
ACADIA Pharmaceuticals Inc
$365
Supernus Pharmaceuticals, Inc.
$331
Genentech USA, Inc.
$321
ARGENX US, INC.
$311
Amgen Inc.
$269
Lundbeck LLC
$253
Neurocrine Biosciences, Inc.
$235
PFIZER INC.
$232
Biohaven Pharmaceutical Holding Company Ltd.
$220
Lilly USA, LLC
$186
Acorda Therapeutics, Inc
$180
Horizon Therapeutics plc
$164
AbbVie Inc.
$152
Alexion Pharmaceuticals, Inc.
$149
SK Life Science, Inc.
$145
Sunovion Pharmaceuticals Inc.
$143
Amneal Pharmaceuticals LLC
$132
MDD US Operations, LLC
$111
Takeda Pharmaceuticals U.S.A., Inc.
$107
Bayer HealthCare Pharmaceuticals Inc.
$90
Janssen Pharmaceuticals, Inc
$85
Alnylam Pharmaceuticals Inc.
$84
Mallinckrodt Hospital Products Inc.
$83
GENZYME CORPORATION
$81
Eisai Inc.
$81
Biohaven Pharmaceuticals, Inc.
$81
JAZZ PHARMACEUTICALS INC.
$79
Avanir Pharmaceuticals, Inc.
$77
Kyowa Kirin, Inc.
$75
Akcea Therapeutics, Inc.
$73
Grifols USA, LLC
$65
US WorldMeds, LLC
$64
EISAI INC.
$61
Upsher-Smith Laboratories LLC
$57
Boston Scientific Corporation
$56
TG Therapeutics, Inc.
$56
Averitas Pharma Inc.
$54
SANOFI-AVENTIS U.S. LLC
$51
Mallinckrodt LLC
$50
Otsuka America Pharmaceutical, Inc.
$48
Bausch Health US, LLC
$40
Jazz Pharmaceuticals Inc.
$38
IMPEL PHARMACEUTICALS INC.
$35
Celgene Corporation
$34
BANNER LIFE SCIENCES, LLC
$33
Mallinckrodt Enterprises LLC
$26
Allergan Inc.
$25
TG THERAPEUTICS, INC.
$23
Neurelis, Inc.
$22
AQUESTIVE THERAPEUTICS, INC.
$20
Banner Life Sciences, LLC
$20
Mitsubishi Tanabe Pharma America, Inc.
$19
AbbVie, Inc.
$19
Medtronic USA, Inc.
$19
Allergan, Inc.
$18
Avion Pharmaceuticals
$16
Harmony Biosciences LLC
$16
Medtronic, Inc.
$15
Abbott Laboratories
$14
LivaNova USA, Inc.
$13
Currax Pharmaceuticals LLC
$13
Top 3 companies account for 22.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · Betaseron · Briviact · CONTRAVE · COPAXONE · CREXONT · DUOPA · Dhivy · Duopa · EMGALITY · EPIDIOLEX · Enspryng · Fintepla · Fycompa · GENERAL - DBS · GILENYA · GOCOVRI · Gamunex-C · Gocovri · HYQVIA · INBRIJA · INFINITY · INGREZZA · INTELLIS ADAPTIVESTIM · KESIMPTA · LEQEMBI · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONPATTRO · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · POMPE - DISEASE · Ponvory · QULIPTA · QUTENZA · RADICAVA · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · SYMPAZAN · TECFIDERA · TEGSEDI · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VECTRIS · VNS Therapy · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WATCHMAN · Wakix · WaveWriter Alpha Prime 16 · Xadago · ZEPOSIA · ZOMIG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
67
Per 100K population
12.3
County median income
$66,027
Nearest hospital
NOVANT HEALTH THOMASVILLE MEDICAL CENTER
7.8 mi
7.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kirby is a mixed practice specialist, with above-average Medicare volume (top 7% in NC), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kirby experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Kirby performed 12,245 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kirby receive payments from pharmaceutical companies?
Yes. Dr. Kirby received a total of $9,584 from 67 companies across 541 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kirby's costs compare to other neurologists in High Point?
Dr. Kirby's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kirby) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in High Point
Browse neurologists in High Point ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NC
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NC
Which NC neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology